Walgreens Boots Alliance is showing signs of recovery that could well continue through the current fiscal year.
It comes after a rough 2020 fiscal year, with data from Finaria showing that the company was one of the three worst-performing stocks on the Dow Jones Index for the entire year. In December, it was down 26%, while the index as a whole showed a 5% increase over the same period.
By the end of the year its stock was down almost 30% from its January 2020 price. Still, it was valued at $48.50 per share as of February 3, 2021, which is more than a 21% increase year-over-year, contributing to an overall market value of $42.28 billion.
A bonus for these communities : Preparing for Federal Retail Pharmacy Program
The first shipments through the program are expected this week Share Updated: 6:13 PM CST Feb 10, 2021
The first shipments through the program are expected this week Share Updated: 6:13 PM CST Feb 10, 2021
Hide Transcript
Show Transcript VACCINATED. REPEAT RICKETTS AS THE STATE DOES NOT KNOW HOW MANY. DOSES TO EXPECT FROM THE FEDERAL RETAIL PHARMACY PROGRAM THAT STARTS THURSDAY. HE SAYS WALMART WILL TAKE PART THOUGH. WE KNOW SMALLER PHARMACIES WILL TOO KETV NEWSWATCH 7’S ALEXANDER STONE IS LIVE WITH NEW DETAILS, JULIE ROB. WE’VE CERTAINLY HEARD A LOT OF DISCUSSION ABOUT THIS FEDERAL RETAIL PHARMACY PROGRAM THE SHIPMENT SCHEDULED TO START THIS WEEK TONIGHT. WE’RE GETTING A BETTER SENSE OF WHAT IT WILL LOOK. LIKE IN NEBRASKA AND IOWA THOUSANDS OF PHARMACIES NATIONWIDE ARE PREPARING FOR THE LAUNCH OF THE FEDERAL RETAIL PHARMACY PROGRAM HOPING IT WILL HELP RAMP UP